Vol 13, No 3 (June 29, 2022) - Journal of Gastrointestinal Oncology

Original Article

Prognosis of patients with esophageal squamous cell carcinoma undergoing surgery versus no surgery after neoadjuvant chemoradiotherapy: a retrospective cohort study

Jiawei Li, Baofu Chen, Xia Wang, Congcong Xu, Dong Chen, Kanghao Zhu, Zixian Jin, Hongbin Qiu, Jianfei Shen, Minhua Ye

Journal of Gastrointestinal Oncology

2022;

(3)

:903-911

(29 June 2022)

PDF Full Text (1762) Reporting Checklist Data Sharing Statement COI Form Open Access

Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion

Delin Liu, Hui Jia, Jianwei Lu, Xi Zou, Ting Qian, Fanyu Peng, Guochun Cao, Min Wang, Shenlin Liu

Journal of Gastrointestinal Oncology

2022;

(3)

:912-922

(29 June 2022)

PDF Full Text (1723) Reporting Checklist Data Sharing Statement COI Form Open Access

Predictive effect of J waves on cardiac compression and clinical prognosis of esophageal tumors: a retrospective study

Songcui Shen, Yichen Xie, Pengliang Ju, Wenzhao Li, Jiayuan Zhang, Ruxin Cai, Ruogu Li

Journal of Gastrointestinal Oncology

2022;

(3)

:923-934

(29 June 2022)

PDF Full Text (1295) Reporting Checklist Data Sharing Statement COI Form Open Access

Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database

Jing Guo, Chang-Yong Tong, Jian-Guang Shi, Xin-Jian Li

Journal of Gastrointestinal Oncology

2022;

(3)

:935-948

(29 June 2022)

PDF Full Text (1490) Reporting Checklist COI Form Open Access

Treatment heterogeneity and overall survival in patients with advanced/metastatic gastric or gastroesophageal junction adenocarcinoma in the United States

Jessica A. Davis, Zhanglin Lin Cui, Madiha Ghias, Xiaohong Li, Robert Goodloe, Chunxiao Wang, Astra M. Liepa, Lisa M. Hess

Journal of Gastrointestinal Oncology

2022;

(3)

:949-957

(29 June 2022)

PDF Full Text (2313) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells

Donghua Geng, Huiying Wu

Journal of Gastrointestinal Oncology

2022;

(3)

:958-967

(29 June 2022)

PDF Full Text (2195) Reporting Checklist Data Sharing Statement COI Form Open Access

The efficacy and safety of continuous intra-arterial infusion neoadjuvant chemotherapy with surgery for locally advanced gastric cancer: a preliminary pilot study

Bin Li, Rui Tang, Guangqiang Zhang, Jingkai Cheng, Ming Chao, Kefeng Ding

Journal of Gastrointestinal Oncology

2022;

(3)

:968-976

(29 June 2022)

PDF Full Text (1636) Reporting Checklist Data Sharing Statement COI Form Open Access

Chemosensitivity of gastric cancer: analysis of key pathogenic transcription factors

Jianze Weng, Aixiang Wu, Jingwen Ying

Journal of Gastrointestinal Oncology

2022;

(3)

:977-984

(29 June 2022)

PDF Full Text (1858) Reporting Checklist COI Form Open Access

Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway

Zhuying Yang, Liang Xia

Journal of Gastrointestinal Oncology

2022;

(3)

:985-996

(29 June 2022)

PDF Full Text (2209) Reporting Checklist Data Sharing Statement COI Form Open Access

Association between preoperative nutritional status, inflammation, and intestinal permeability in elderly patients undergoing gastrectomy: a prospective cohort study

Xining Zhao, Ying Wang, Yuying Yang, Yan Pan, Jie Liu, Shengjin Ge

Journal of Gastrointestinal Oncology

2022;

(3)

:997-1006

(29 June 2022)

PDF Full Text (1947) Reporting Checklist Data Sharing Statement COI Form Open Access

Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer

Yueyue Zhu, Wenjing Zhao, Guoxin Mao

Journal of Gastrointestinal Oncology

2022;

(3)

:1007-1021

(29 June 2022)

PDF Full Text (1978) Reporting Checklist Data Sharing Statement COI Form Open Access

A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin

Xiaolin Lin, Ting Han, Meng Zhuo, Tengfei Liu, Zebing Liu, Dongxi Xiang, Hong Li, Xiuying Xiao

Journal of Gastrointestinal Oncology

2022;

(3)

:1022-1034

(29 June 2022)

PDF Full Text (2793) Reporting Checklist Data Sharing Statement COI Form Open Access

Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer

Weiwei Weng, Meng Zhang, Shujuan Ni, Cong Tan, Midie Xu, Xin Wang, Hui Sun, Lei Wang, Dan Huang, Weiqi Sheng

Journal of Gastrointestinal Oncology

2022;

(3)

:1035-1045

(29 June 2022)

PDF Full Text (2790) Reporting Checklist Data Sharing Statement COI Form Open Access

Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study

Yi Wang, Handong Xu, Can Hu, Pengcheng Yu, Zhehan Bao, Yanqiang Zhang, Ruolan Zhang, Shengjie Zhang, Bing Li, Jean-Marie Aerts, Zhiyuan Xu, Xiangdong Cheng

Journal of Gastrointestinal Oncology

2022;

(3)

:1046-1057

(29 June 2022)

PDF Full Text (1929) Reporting Checklist Data Sharing Statement COI Form Open Access

Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer

Wen Li, Honghui Chen, Zhenggen Wang, Jingjing Liu, Xinan Lei, Wen Chen

Journal of Gastrointestinal Oncology

2022;

(3)

:1058-1072

(29 June 2022)

PDF Full Text (2555) Reporting Checklist Data Sharing Statement COI Form Open Access

Efficacy of hand-assisted laparoscopic surgery (HALS) in older adult patients (≥80 years) with primary colorectal cancer

Takuya Koike, Masaya Mukai, Rin Abe, Yutaro Kamei, Daiki Yokoyama, Shuji Uda, Shigeo Higami, Sayuri Hasegawa, Tomoki Nakamura, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuchi

Journal of Gastrointestinal Oncology

2022;

(3)

:1073-1080

(29 June 2022)

PDF Full Text (1621) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital

Michael Padgett, Shivam M. Kharod, Catherine E. Mercado, Christopher G. Morris, Michael S. Rutenberg, Romaine C. Nichols Jr

Journal of Gastrointestinal Oncology

2022;

(3)

:1081-1085

(29 June 2022)

PDF Full Text (1526) Reporting Checklist Data Sharing Statement COI Form Open Access

The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis

Li-Na Zhou, Chun-Xia Feng, Yan Zhang, Ping Li, Min Tang, Min-Bin Chen, Jun Jin

Journal of Gastrointestinal Oncology

2022;

(3)

:1086-1096

(29 June 2022)

PDF Full Text (1477) Reporting Checklist Data Sharing Statement COI Form Open Access

Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway

Yanjiao Guo, Yiming Zhou, Xiaodong Gu, Jianbin Xiang

Journal of Gastrointestinal Oncology

2022;

(3)

:1097-1111

(29 June 2022)

PDF Full Text (1669) Reporting Checklist Data Sharing Statement COI Form Open Access

Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial

Xinghui Li, Jinwen Shen, Fan Xia, Ji Zhu

Journal of Gastrointestinal Oncology

2022;

(3)

:1112-1120

(29 June 2022)

PDF Full Text (1896) Reporting Checklist Data Sharing Statement COI Form Open Access

Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors

Yan Weng, Jingxue Ran, Yongmei Peng, Yining Xiang, Liangbi Xu

Journal of Gastrointestinal Oncology

2022;

(3)

:1121-1131

(29 June 2022)

PDF Full Text (1618) Reporting Checklist Data Sharing Statement COI Form Open Access

TRIM29 is differentially expressed in colorectal cancers of different primary locations and affects survival by regulating tumor immunity based on retrospective study and bioinformatics analysis

Jing Han, Jing Zuo, Xue Zhang, Long Wang, Dan Li, Yudong Wang, Jiayin Liu, Li Feng

Journal of Gastrointestinal Oncology

2022;

(3)

:1132-1151

(29 June 2022)

PDF Full Text (1886) Reporting Checklist Data Sharing Statement COI Form Open Access

c-MYC and HIF1α promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer

Lina Wen, Zongqiang Han, Jianhui Li, Yanlin Du

Journal of Gastrointestinal Oncology

2022;

(3)

:1152-1168

(29 June 2022)

PDF Full Text (2906) Reporting Checklist Data Sharing Statement COI Form Open Access

Suppression effect and safety of acupuncture on colonic spasm during colonoscopy: a randomized controlled trial

Baoling Chen, Yanyan Ma, Cailing Zhong, Ye Li, Jiahao Mo, Songming Liang, Yao Zhong, Beiping Zhang, Yingxian Li

Journal of Gastrointestinal Oncology

2022;

(3)

:1169-1177

(29 June 2022)

PDF Full Text (2034) Reporting Checklist Trial Protocol Data Sharing Statement COI Form Open Access

Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome Atlas database

Ruofan Li, Xu Gao, Haitao Sun, Lixin Sun, Xiaojian Hu

Journal of Gastrointestinal Oncology

2022;

(3)

:1178-1187

(29 June 2022)

PDF Full Text (2057) Reporting Checklist COI Form Open Access

Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis

Yan-Rong Li, Ke Meng, Guang Yang, Bao-Hai Liu, Chu-Qiao Li, Jia-Yuan Zhang, Xiao-Mei Zhang

Journal of Gastrointestinal Oncology

2022;

(3)

:1188-1203

(29 June 2022)

PDF Full Text (3439) Reporting Checklist COI Form Open Access

Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer

Jesus C. Fabregas, Kristen E. Riley, Jeannine M. Brant, Thomas J. George, E. John Orav, Miranda B. Lam

Journal of Gastrointestinal Oncology

2022;

(3)

:1204-1214

(29 June 2022)

PDF Full Text (2541) Reporting Checklist COI Form Open Access

Clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy: systematic review and meta-analysis

Jihua Jiang, Lei Pei, Renya Jiang

Journal of Gastrointestinal Oncology

2022;

(3)

:1215-1223

(29 June 2022)

PDF Full Text (2046) Reporting Checklist COI Form Open Access

Diagnostic accuracy of 3D imaging combined with intra-operative ultrasound in the prediction of post-hepatectomy liver failure

Tianchong Wu, Wenhao Huang, Baochun He, Yuehua Guo, Gongzhe Peng, Mingyue Li, Shiyun Bao

Journal of Gastrointestinal Oncology

2022;

(3)

:1224-1236

(29 June 2022)

PDF Full Text (1556) Reporting Checklist Data Sharing Statement COI Form Open Access

ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A1

Wenping Song, Weijiang Yu, Ding Li, Cheng Cheng, Xuan Wu, Jinhua Chen, Wenzhou Zhang

Journal of Gastrointestinal Oncology

2022;

(3)

:1237-1247

(29 June 2022)

PDF Full Text (3523) Reporting Checklist Data Sharing Statement COI Form Open Access

Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy

Haochen Wang, Weizhong Xiao, Yanjing Han, Shasha Cao, Zhiyuan Zhang, Guang Chen, Yuefeng Hu, Long Jin

Journal of Gastrointestinal Oncology

2022;

(3)

:1248-1254

(29 June 2022)

PDF Full Text (1653) Reporting Checklist Data Sharing Statement COI Form Open Access

Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells

Rong Bian, Jinkai Zhao, Zhongcai Yao, Yajun Cai, Chenting Shou, Dayong Lou, Liqin Zhou, Yuanyuan Qian

Journal of Gastrointestinal Oncology

2022;

(3)

:1255-1265

(29 June 2022)

PDF Full Text (1786) Reporting Checklist Data Sharing Statement COI Form Open Access

Efficacy and safety of sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a two-center study in China

Shao-Hua Ren, Zi-Lin Cui, Meng-Ran Lang, Qiang Li, Wei Zhang, Feng Fang, Qiang Wu, Yun-Long Cui, Hui-Kai Li, Ping Chen, Yamin Zhang, Tianqiang Song

Journal of Gastrointestinal Oncology

2022;

(3)

:1266-1277

(29 June 2022)

PDF Full Text (2050) Reporting Checklist Data Sharing Statement COI Form Open Access

Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study

Jian Zhai, Jianwei Liu, Zhigang Fu, Shilei Bai, Xiaowei Li, Zengqiang Qu, Yanfu Sun, Ruiliang Ge, Feng Xue

Journal of Gastrointestinal Oncology

2022;

(3)

:1278-1288

(29 June 2022)

PDF Full Text (2097) Reporting Checklist Data Sharing Statement COI Form Open Access

Exploring potential targets of Actinidia Chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma

Meilin Qu, Tao Han, Xiaoquan Chen, Qingqing Sun, Qing Li, Mingfang Zhao

Journal of Gastrointestinal Oncology

2022;

(3)

:1289-1307

(29 June 2022)

PDF Full Text (2283) Reporting Checklist COI Form Open Access

Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma

Simiao Zhang, Lixia Hou, Qingyu Sun

Journal of Gastrointestinal Oncology

2022;

(3)

:1308-1316

(29 June 2022)

PDF Full Text (2086) Reporting Checklist Data Sharing Statement COI Form Open Access

IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma

Wei Chen, Mingjuan Hu, Tao Wei, Ying Liu, Tian Tan, Chengfang Zhang, Jiaxuan Weng

Journal of Gastrointestinal Oncology

2022;

(3)

:1317-1329

(29 June 2022)

PDF Full Text (1860) Reporting Checklist Data Sharing Statement COI Form Open Access

Antidiabetic treatment improves prognosis after radical resection in hepatocellular carcinoma patients with diabetes mellitus: a retrospective cohort study from 2000 to 2013

Jing-Zhu Cao, Zhen-Guang Wang, Jian Yu, Yuan-Ping Tao, Yuan Yang, Hui Liu, Wei-Ping Zhou, Jin Lu, Qin Huang

Journal of Gastrointestinal Oncology

2022;

(3)

:1330-1339

(29 June 2022)

PDF Full Text (1608) Reporting Checklist Data Sharing Statement COI Form Open Access

Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study

Zeyu Wang, Zhongyi Dong, Gang Zhao, Bo Ni, Zi-Zhen Zhang

Journal of Gastrointestinal Oncology

2022;

(3)

:1340-1350

(29 June 2022)

PDF Full Text (1651) Reporting Checklist Data Sharing Statement COI Form Open Access

Clinical significance and immunogenomic landscape analysis of glycolysis-associated prognostic model to guide clinical therapy in hepatocellular carcinoma

Qingshan Chen, Leilei Bao, Yueying Huang, Lei Lv, Guoqing Zhang, Yi Chen

Journal of Gastrointestinal Oncology

2022;

(3)

:1351-1366

(29 June 2022)

PDF Full Text (2005) Reporting Checklist COI Form Open Access

Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study

Ruiqing Chen, Lingbing Li, Ye Li, Ke Song, Chenyu Shen, Pengkai Ma, Zhijun Wang

Journal of Gastrointestinal Oncology

2022;

(3)

:1367-1375

(29 June 2022)

PDF Full Text (1965) Reporting Checklist Data Sharing Statement COI Form Open Access

Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma

Jixue Zou, Jia Yuan, Hong Chen, Xinghao Zhou, Tongchun Xue, Rongxin Chen, Lan Zhang, Zhenggang Ren

Journal of Gastrointestinal Oncology

2022;

(3)

:1376-1383

(29 June 2022)

PDF Full Text (1781) Reporting Checklist Data Sharing Statement COI Form Open Access

Human chorionic gonadotropin-β promotes pancreatic cancer progression via the epithelial mesenchymal transition signaling pathway

Yasunori Uesato, Futoshi Kawamata, Shinichiro Ishino, Shinichiro Ono, Koichi Tamashiro, Hirofumi Koyama, Mitsuhisa Takatsuki

Journal of Gastrointestinal Oncology

2022;

(3)

:1384-1394

(29 June 2022)

PDF Full Text (1431) Reporting Checklist Data Sharing Statement COI Form Open Access

Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trial

Cooper T. Rapp, Michael S. Rutenberg, Christopher G. Morris, Romaine C. Nichols

Journal of Gastrointestinal Oncology

2022;

(3)

:1395-1401

(29 June 2022)

PDF Full Text (1466) Reporting Checklist Data Sharing Statement COI Form Open Access

Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection

Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang

Journal of Gastrointestinal Oncology

2022;

(3)

:1402-1412

(29 June 2022)

PDF Full Text (2550) Reporting Checklist Data Sharing Statement COI Form Open Access

Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?

Andrew J. Sinnamon, Anthony C. Wood, Megan A. Satyadi, Catherine V. Levitt, Olivia Hardy, Mintallah Haider, Richard D. Kim, Daniel A. Anaya, Jason W. Denbo

Journal of Gastrointestinal Oncology

2022;

(3)

:1413-1422

(29 June 2022)

PDF Full Text (1512) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access